Business Wire

New 12-month Results from the VATRAC Trial Confirm Durable Efficacy of Aerin Medical’s VivAer ® in Patients with Nasal Valve Collapse

Treatment with VivAer was well-tolerated, with no serious adverse events related to the procedure or device. “Study after study, physician investigators have demonstrated that treatment with VivAer ...
Business Wire

Four-Year Results Show Aerin Medical’s VivAer® Treatment Provides Significant, Sustained Relief of Nasal Obstruction Symptoms

SUNNYVALE, Calif.--(BUSINESS WIRE)--Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced ...
Healio

Q&A: Managing patients with central airway obstruction

Please provide your email address to receive an email when new articles are posted on . The American College of Chest Physicians published a clinical practice guideline on management of central airway ...
Victoria Advocate

DeTar introduces new sleep apnea treatment system

DeTar Healthcare System is pleased to announce that the upper airway stimulation system, an advanced treatment option for ...
The Bakersfield Californian

Aerin Medical Announces Long-Term Study Demonstrating Sustained Relief for Nasal Airway Obstruction Symptoms

Aerin Medical, Inc., a leader in minimally invasive solutions for chronic nasal conditions, today announced the publication of positive three-year results from VATRAC, a randomized controlled trial ...
Healio

Odds for future airway obstruction elevated with preserved ratio impaired spirometry

Please provide your email address to receive an email when new articles are posted on . The link between preserved ratio impaired spirometry (PRISm) and airway obstruction development was independent ...